BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33005796
Number of visits today
6430
Number of downloads
16194211
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Medina-Pestana J, Almeida Viana L, Nakamura MR, Lucena EF, Granato CFH, Dreige YC, Amorim LVP, Chow CYZ, Demarchi Foresto R, Roberto Requião-Moura L, Tedesco-Silva H, Cristelli MP. Immunogenicity After a Heterologous BNT262b2 Versus Homologous Booster in Kidney Transplant Recipients Receiving 2 Doses of CoronaVac Vaccine: A Prospective Cohort Study. Transplantation 2022. [PMID: 35939382 DOI: 10.1097/TP.0000000000004260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Petr V, Zahradka I, Modos I, Roder M, Prewett A, Fialova M, Machkova J, Hruba P, Magicova M, Slavcev A, Striz I, Viklicky O. First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft. Transplantation 2023;107:e62-4. [PMID: 36314999 DOI: 10.1097/TP.0000000000004421] [Reference Citation Analysis]
2 Erol Ç, Kuloğlu ZE, Kayaaslan B, Esken G, Altınsoy A, Barlas T, Çınar G, Hasanoğlu İ, Oruç E, İncir S, Azap A, Korkmaz G, Gökçe DT, Kırımker OE, Yenigün EC, Ölçücüoğlu E, Soy EA, Çetinkünar S, Azap ÖK, Can F, Haberal M. BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses Among Transplant Recipients Who Had Received Two Doses of CoronaVac.. [DOI: 10.21203/rs.3.rs-2316160/v1] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345